OTC Pharmaceuticals - Pakistan | Statista Market Forecast

In 2024, the revenue in Pakistan's OTC Pharmaceuticals market is estimated to reach US$524.30m.
It is projected to experience an annual growth rate of 6.79% (CAGR 2024-2029).
Among the various markets, the Analgesics market holds the largest share, with a market volume of US$123.40m in 2024.
When compared globally, the United States generates the highest revenue, amounting to US$41.24bn in 2024.
In terms of per capita revenue, in Pakistan generates US$2.14 per person in 2024.
Additionally, online sales are expected to contribute 17.61% of the total revenue in the OTC Pharmaceuticals market by 2024.
Despite a growing demand for OTC Pharmaceuticals in Pakistan, the lack of regulatory oversight poses potential risks to consumer safety.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Pakistan has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the OTC Pharmaceuticals market in Pakistan have been shifting towards self-medication and convenience. With increasing awareness and access to information through the internet and social media, consumers are becoming more knowledgeable about their health and are seeking ways to address common health issues on their own. This has led to a growing demand for over-the-counter medications that can be easily purchased without a prescription. Additionally, the busy lifestyles of consumers in Pakistan have also contributed to the preference for OTC medications, as they provide a quick and convenient solution to minor health problems.Trends in the OTC Pharmaceuticals market in Pakistan reflect global and regional market developments. One of the key trends is the rising popularity of natural and herbal remedies. Consumers are increasingly seeking products that are perceived as more natural and have fewer side effects. This has led to a growing demand for herbal and alternative medicine products in the OTC Pharmaceuticals market. Another trend is the increasing availability of OTC medications in modern retail channels such as pharmacies and supermarkets. This has improved accessibility and convenience for consumers, further driving the growth of the market.Local special circumstances in Pakistan have also contributed to the development of the OTC Pharmaceuticals market. The country has a large population with limited access to healthcare services, particularly in rural areas. This has created a need for easily accessible and affordable healthcare solutions, which OTC medications can provide. Additionally, the lack of healthcare infrastructure and shortage of healthcare professionals in certain regions have further fueled the demand for self-medication options.Underlying macroeconomic factors have played a role in the growth of the OTC Pharmaceuticals market in Pakistan. The country has been experiencing economic growth, which has led to an increase in disposable income and improved living standards for many consumers. This has resulted in higher healthcare spending and a greater willingness to invest in self-care products. Furthermore, the government has been promoting the development of the pharmaceutical industry, which has created a favorable environment for the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Pakistan is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication and convenience, the rising popularity of natural and herbal remedies, the increasing availability of OTC medications in modern retail channels, limited access to healthcare services, economic growth, and government support for the pharmaceutical industry are all contributing to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.